Ramipril Capsule
FDA Label NDC 65841-657

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Ramipril (NDC 65841-657). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-655-06 in bottle of 30 Capsules

Ramipril Capsules, 1.25 mg

Rx only

30 Capsules

Ramipril Capsules, 1.25 mg (Cd70405e Bbd2 42ac 89e6 20bfe39f8601 02)

Ramipril Capsules, 1.25 mg (Cd70405e Bbd2 42ac 89e6 20bfe39f8601 02)

NDC 65841-656-01 in bottle of 100 Capsules

Ramipril Capsules, 2.5 mg

Rx only

100 Capsules

Ramipril Capsules, 2.5 mg (Cd70405e Bbd2 42ac 89e6 20bfe39f8601 03)

Ramipril Capsules, 2.5 mg (Cd70405e Bbd2 42ac 89e6 20bfe39f8601 03)

NDC 65841-657-01 in bottle of 100 Capsules

Ramipril Capsules, 5 mg

Rx only

100 Capsules

Ramipril Capsules, 5 mg (Cd70405e Bbd2 42ac 89e6 20bfe39f8601 04)

Ramipril Capsules, 5 mg (Cd70405e Bbd2 42ac 89e6 20bfe39f8601 04)

NDC 65841-658-01 in bottle of 100 Capsules

Ramipril Capsules, 10 mg

Rx only

100 Capsules

Ramipril Capsules, 10 mg (Cd70405e Bbd2 42ac 89e6 20bfe39f8601 05)

Ramipril Capsules, 10 mg (Cd70405e Bbd2 42ac 89e6 20bfe39f8601 05)

* Please review the disclaimer below.